Vitamin D and breast cancer
Record ID 32013000214
English
Authors' recommendations:
Women diagnosed with breast cancer typically have levels of vitamin D that are below the level considered sufficient for optimal health. Given the regulatory roles played by vitamin D for tumor control within breast tissue and for general bone health, vitamin D sufficiency may improve breast cancer outcomes as well as improve the safety and effectiveness of breast cancer treatments. Vitamin D testing measures the circulating levels of 25-hydroxyvitamin D (25-OHD), the molecule that best represents vitamin D status. Vitamin D supplementation is intended to improve circulating levels of 25-OHD.
Details
Project Status:
Completed
Year Published:
2012
URL for published report:
The report may be purchased from:http://www.hayesinc.com/hayes/crd/?crd=14619
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Vitamin D
Contact
Organisation Name:
HAYES, Inc.
Contact Address:
157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218
Contact Name:
saleinfo@hayesinc.com
Contact Email:
saleinfo@hayesinc.com
Copyright:
2012 Winifred S. Hayes, Inc
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.